Truth: Semaglutide and Tirzepatide complement a healthy lifestyle, regulating appetite and enhancing weight loss, but a balanced diet and exercise are essential
Until such evidence is available for retatrutide, therapies with established cardiovascular and renal benefitssuch as semaglutide, supported by SUSTAIN-6 [5] and FLOW [57] trials in people with T2D, and the SELECT trial [58] in people with obesity - should be prioritised in populations with existing cardio-renal disease
See Whether You Qualify for GLP-1 Treatment Complete a 5-minute intake so a licensed provider can review your health history, weight goals, and whether GLP-1 treatment may be appropriate
Therefore, patients treated with Ozempic or Wegovy experienced significant reductions in body weight compared to a placebo
Get the latest advice from our longevity experts and early access to updated mixing guides, clinical insights, and exclusive access